Amanote Research

Amanote Research

    RegisterSign In

Sarilumab for the Treatment of Rheumatoid Arthritis

Immunotherapy - United Kingdom
doi 10.2217/imt.15.127
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyAllergyImmunology
Date

March 1, 2016

Authors
Simon Cooper
Publisher

Future Medicine Ltd


Related search

Profile of Sarilumab and Its Potential in the Treatment of Rheumatoid Arthritis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis

Medical Council
2019English

Sarilumab: A New IL-6 Receptor Blocker for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

Pms84 - Comparison of Hta Assessments of Sarilumab in Different Subpopulations for Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients With Rheumatoid Arthritis

Clinical Pharmacokinetics
Pharmacology
2016English

The Treatment of Rheumatoid Arthritis.

JAMA - Journal of the American Medical Association
Medicine
1929English

Treatment of Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1997English

Treatment of Rheumatoid Arthritis

1981English

Treatment of Rheumatoid Arthritis

BMJ
1949English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy